Aliment Pharmacol Ther

1. SHUNG DL, Laine L
   Review article: Upper gastrointestinal bleeding - review of current evidence and implications for management.
   Aliment Pharmacol Ther. 2024 Mar 22. doi: 10.1111/apt.17949.
   

   >> Share

   
   

   
   Dig Dis Sci

2. LIU SZ, Lee TL, Tai CM
   A Rare Cause of Upper Gastrointestinal Bleeding.
   Dig Dis Sci. 2024 Mar 19. doi: 10.1007/s10620-024-08371.
   

   >> Share

   
   
3. PATIAL P, Yadav A, Lal R, Rohilla M, et al
   Endoscopic Ultrasound in Non-healing Gastric Ulcer.
   Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08386.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

4. QIAO Z, Wang E, Bao B, Tan X, et al
   Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis.
   Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002765.
   

   >> Share

   
   
5. LIU Z, Sun D, Kou L, Jia L, et al
   Vonoprazan-amoxicillin dual therapy with different amoxicillin dosages for treatment-naive patients of Helicobacter pylori infection in China: a prospective, randomized controlled study.
   Eur J Gastroenterol Hepatol. 2024 Mar 19. doi: 10.1097/MEG.0000000000002760.
   

   >> Share

   
   

   
   Gastroenterology

6. KALLUMKAL G, McCallen J, Contarino M
   Recurrent Duodenal Ulceration - More Than Simple Peptic Ulcer Disease?
   Gastroenterology. 2024 Mar 24:S0016-5085(24)00354.
   

   >> Share

   
   
7. KIM H, Nzabarushimana E, Huttenhower C, Chan AT, et al
   Altered microbial transcription in long-term proton pump inhibitor usage: findings from a US cohort study.
   Gastroenterology. 2024 Mar 21:S0016-5085(24)00309.
   

   >> Share

   
   
8. WIKLUND AK, Santoni G, Yan J, Radkiewicz C, et al
   Risk of esophageal adenocarcinoma after Helicobacter pylori eradication treatment in a population-based multinational cohort study.
   Gastroenterology. 2024 Mar 19:S0016-5085(24)00299.
   

   >> Share

   
   
9. XU J, Deng M, Tang X
   Comments on "Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022".
   Gastroenterology. 2024 Mar 15:S0016-5085(24)00294.
   

   >> Share

   
   
10. LI GF, Qiao YW, Yu G
    Helicobacter pylori Therapy and Risk of Gastric Cancer After Endoscopic Resection of Dysplasia: A Sensitivity Analysis Assessing Impact of Unmeasured Confounding.
    Gastroenterology. 2024 Mar 14:S0016-5085(24)00292.
    

    >> Share

    
    

    
    Helicobacter

11. APOORVA E, Jacob R, Rao DN, Kumar S, et al
    Helicobacter pylori enhances HLA-C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells.
    Helicobacter. 2024;29:e13069.
    

    >> Share

    
    
12. PEYPAR MH, Yeganeh AV, Ramazani A, Alizadeh A, et al
    Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review.
    Helicobacter. 2024;29:e13067.
    

    >> Share

    
    
13. OKAMURA T, Iwaya Y, Nagaya T, Horiuchi K, et al
    Diagnosis by combination of endoscopic findings helps differentiate non-Helicobacter pylori Helicobacter-infected gastritis from Helicobacter pylori-infected gastritis.
    Helicobacter. 2024;29:e13070.
    

    >> Share

    
    
14. LUO Q, Liu C, Zhang A, Zhang D, et al
    Research progress in photodynamic therapy for Helicobacter pylori infection.
    Helicobacter. 2024;29:e13068.
    

    >> Share

    
    

    
    J Ethnopharmacol

15. PAN S, Yu X, Liu M, Liu J, et al
    Banxia Xiexin decoction promotes gastric lymphatic pumping by regulating lymphatic smooth muscle cell contraction and energy metabolism in a stress-induced gastric ulceration rat model.
    J Ethnopharmacol. 2024;328:118015.
    

    >> Share

    
    

    
    J Pharm Pharmacol

16. BINGANA RD, Nicolau LAD, Sales TMAL, Paula SM, et al
    Exploring the clinical relevance of "Angico Gum": an effective biopolymer for topical protection of oesophageal mucosa in gastroesophageal reflux disease patients.
    J Pharm Pharmacol. 2024 Mar 28:rgae032. doi: 10.1093.
    

    >> Share

    
    

    
    Minerva Gastroenterol (Torino)

17. CONTI BELLOCCHI MC, Gasparini E, DI Stefano S, Bobba V, et al
    The real-time analysis of gastric juice (Endofaster) for detection of Helicobacter Pylori: a reliable tool in substitution of histology.
    Minerva Gastroenterol (Torino). 2024 Mar 26. doi: 10.23736/S2724-5985.23.03480.
    

    >> Share

    
    
18. ARAGONA SE, Fabbri C, Cammarota G, Ciprandi G, et al
    Probiotic mixture in patients after Helicobacter pylori eradication: a real-life experience.
    Minerva Gastroenterol (Torino). 2024 Mar 26. doi: 10.23736/S2724-5985.24.03634.
    

    >> Share

    
    

    
    Surg Endosc

19. SACHAR M, Wizentier M, Risner E, Asmail H, et al
    Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).
    Surg Endosc. 2024 Mar 25. doi: 10.1007/s00464-024-10714.
    

    >> Share

    
    
20. KERMANSARAVI M, Shahsavan M, Ebrahimi R, Mousavimaleki A, et al
    Effect of anti-reflux suture on gastroesophageal reflux symptoms after one anastomosis gastric bypass: a randomized controlled trial.
    Surg Endosc. 2024 Mar 18. doi: 10.1007/s00464-024-10792.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share